Edmond de Rothschild Asset Management (France)’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q3	$16.6M	Sell	190,000 -10,000	-5%	-$872K	0.72%	43
2016 Q2	$17.2M	Buy	200,000 +11,700	+6%	+$1.01M	0.77%	40
2016 Q1	$15M	Buy	188,300 +58,300	+45%	+$4.63M	0.65%	48
2015 Q4	$16.4M	Buy	130,000 +15,000	+13%	+$1.89M	0.58%	54
2015 Q3	$12M	Buy	+115,000	New	+$12M	0.4%	67